Breaking

Pakistan fears India incursion ‘imminent’ amid heightened tensions following terror attack
US strikes kill hundreds of Houthi fighters, hit over 800 Red Sea targets: Central Command
GOP races against clock as Senate, House remain trillions of dollars apart on Trump’s tax bill
DAVID MARCUS: Disband the White House Correspondents’ Association
White House reveals possible penalties on Putin amid peace push: ‘Whatever it takes’
Our Very Last Trading Room
Crypto Market Recap: Bitcoin Holds Above US$90,000, Strategy Bags Another US$1.42 Billion
Hegseth vows crackdown on military obesity after shocking Reserve, Guard report

Investing
Stock
Economy
Editor’s Pick
Latest News
Search for:

Investing

First patient dosed in Phase IIb imaging for Brain Mets

By April 28, 2025

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Crypto Market Recap: Bitcoin Holds Above US$90,000, Strategy Bags Another US$1.42 Billion

SOURCE ROCK ROYALTIES ANNOUNCES FOURTH QUARTER & YEAR-END 2024 RESULTS INCLUDING RECORD ANNUAL FUNDS FROM OPERATIONS

Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain Metastasis

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.
Your name

Your email
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
Popular News

Latest Posts
Categories
- Economy (40)
- Editor's Pick (66)
- Investing (250)
- Latest News (402)
- Stock (20)
About Greencandlemarkets.com

Disclaimer: Greencandlemarkets.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 Greencandlemarkets.com

Top

Type above and press Enter to search. Press Esc to cancel.